Marker Predicts Good Results With Stem Cells – MedPage Today
|
Marker Predicts Good Results With Stem Cells
MedPage Today Survival improved by 60% and disease progression decreased by 62% in 313 patients who received allogeneic hematopoietic stem cells containing killer-cell immunoglobulin-like receptor 2DL1 (KIR2DL1). Patients benefited regardless of the indication for … |
